# The Health Service Products (Provision and Disclosure of Information) Regulations 2018, Paragraph 2: Meaning of “presentation of health service medicine”


(1) This paragraph defines “presentation of health service medicine” and related terms for the purposes of these Regulations.
(2) “Presentation of health service medicine” means—
(a) a presentation of unbranded generic health service medicine,
(b) a presentation of made special health service medicine,
(c) a presentation of imported special health service medicine, or
(d) a presentation of any other health service medicine.
(3) “Presentation of unbranded generic health service medicine” means a particular unbranded generic health service medicine which may be distinguished from all other such medicines by reference to—
(a) its active ingredients,
(b) its strength,
(c) its physical form,
(d) its unit dose (if applicable),
(e) its method of administration (if applicable),
(f) its freeness (if applicable),
(g) its pack size, and
(h) the type of its packaging.
(4) “Presentation of made special health service medicine” means a particular made special health service medicine which may be distinguished from all other such medicines by reference to—
(a) its active ingredients,
(b) its strength,
(c) its physical form,
(d) its unit dose (if applicable), and
(e) its method of administration (if applicable).
(5) “Presentation of imported special health service medicine” means a particular imported special health service medicine which may be distinguished from all other such medicines by reference to—
(a) its active ingredients,
(b) its strength,
(c) its physical form,
(d) its unit dose (if applicable),
(e) its method of administration (if applicable),
(f) its freeness (if applicable),
(g) its pack size, and
(h) the type of its packaging.
(6) “Presentation of other health service medicine” means a particular health service medicine which may be distinguished from all other other health service medicines by reference to—
(a) its active ingredients,
(b) its strength,
(c) its physical form,
(d) its unit dose (if applicable),
(e) its method of administration (if applicable),
(f) its freeness (if applicable),
(g) its pack size, and
(h) the type of its packaging.
(7) In paragraph (5) “other health service medicine” means a health service medicine which is not an unbranded generic health service medicine or a special health service medicine.

---
Source: https://www.legislation.gov.uk/uksi/2018/677/schedule/1/paragraph/2 (the official version)
Page: https://openlegislation.uk/health-service-products-provision-and-disclosure-of-information-regulations-2018/schedule-1/paragraph-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

